Alfonso Quintás-Cardama
Overview
Alfonso Quintás-Cardama received $2M in total compensation, including $144K in salary, at Foghorn Therapeutics in 2023.
Source: SEC filing on May 3, 2024.
Related executives
We found five more executives who work or worked at Foghorn Therapeutics.